[ Price : $8.95]
Assistant attorney general Tony West says the federal governments comprehensive enforcement action in healthcare fraud has netted ...[ Price : $8.95]
A citizen petition asks FDA for guidance on the degree to which sellers of research materials for non-clinical that are the same a...[ Price : $8.95]
Federal Register Notice: CBER will co-sponsor a public workshop on developing and evaluating human cytomegalovirus vaccines.[ Price : $8.95]
FDA clears a Fresenius Medical Care 510(k) for enhanced features including the Clinical Data Exchange for its 2008T hemodialysis d...[ Price : $8.95]
CDER has outlines the paths for stakeholders to take to resolve disputes with Center staff.[ Price : $8.95]
FDA Webview editor Jim Dickinson sees a disturbing parallel between the Penn State sex scandal and FDAs equally toxic culture of l...[ Price : $8.95]
FDA accepts for review a Genentech NDA for vismodegib, indicated for treating adults with advanced basal cell carcinoma.[ Price : $8.95]
FDA says that ACCORD trial results show that Abbotts Trilipex may not lower a patients risk of heart attack or stroke.